68Ga-FAPI-04 PET/CT Imaging of Mesenteric Aggressive Fibromatosis
Authors:
- 5 April 2024
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (7) , 664-665
Abstract
Aggressive fibromatosis is a relatively rare disease. We describe 68Ga-FAPI-04 PET/CT findings in a case of histologically proved mesenteric aggressive fibromatosis. 68Ga-FAPI-04 PET/CT revealed a mass in the mesentery with increased FAPI activity. This case indicates that FAPI PET may be useful for evaluation of aggressive fibromatosis.Keywords
This publication has 9 references indexed in Scilit:
- Mesenteric Mesonephric Adenocarcinoma on 68Ga-FAPI PET/CTClinical Nuclear Medicine, 2022
- 68Ga-FAPI Versus 18F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon MesenteryClinical Nuclear Medicine, 2022
- Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis on 68Ga-FAPI-04 and 18F-FDG PET/CTClinical Nuclear Medicine, 2022
- Mesenteric Inflammatory Myofibroblastic Tumor on 68Ga-FAPI PET/CTClinical Nuclear Medicine, 2021
- Use of 68Ga-FAPI PET/CT for Evaluation of Peritoneal Carcinomatosis Before and After Cytoreductive SurgeryClinical Nuclear Medicine, 2021
- Fibroblast Activation Protein Inhibitor PET/CTClinical Nuclear Medicine, 2020
- Fibromatosis Associated With Neuromuscular ChoristomaClinical Nuclear Medicine, 2017
- Desmoid tumour (aggressive fibromatosis) of the colon mimics malignancy on dual time-point18F-FDG PET/CT imagingBritish Journal of Radiology, 2012
- Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the managementBritish Journal of Radiology, 2007